🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21306Original Research

Non-invasive brain stimulation for core symptoms in children with autism spectrum disorder: a network meta-analysis

Fang Enhui¹,Guan Hui¹,Ma Lihong¹

School of Rehabilitation Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, Shandong Province, China

Read Executive PreviewQuick FAQ
Non-invasive brain stimulation for core symptoms in children with autism spectrum disorder: a network meta-analysis
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1898, Issue 26 • pp. 100-112Citation:Fang Enhui et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Non-invasive brain stimulation significantly improves core symptoms in children with autism compared to conventional rehabilitation. • High-frequency repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex is most effective for improving Childhood Autism Rating Scale scores. • High-frequency rTMS over Broca's area is most effective for improving Autism Behavior Checklist scores. • The evidence is limited by methodological heterogeneity and small sample sizes, necessitating further high-quality trials.
Sponsored Research Highlight

Abstract

OBJECTIVE: Non-invasive brain stimulation has been shown to improve restricted, repetitive behaviors and social deficits in children with autism; however, the efficacy of different stimulation protocols varies. This study systematically evaluated the efficacy of non-invasive brain stimulation on core symptoms in children with autism and compared the efficacy of different stimulation protocols. METHODS: Comprehensive electronic searches were conducted across CNKI, VIP, WanFang, CBM, PubMed, Embase, Cochrane Library, and Web of Science from database inception through March 2025 to identify randomized controlled trials evaluating non-invasive brain stimulation protocols targeting core symptoms in children with autism spectrum disorder. Two independent reviewers performed dual-phase screening, data extraction, and methodological quality assessment using the Cochrane Risk of Bias Tool version 2.0. Both conventional and network meta-analyses were implemented through Revman 5.4 and Stata 17.0. RESULTS: A total of 27 studies were finally included for review, involving 10 stimulation protocols of non-invasive brain stimulation and including 1 701 children with autism. (1) The results of conventional Meta-analysis showed that non-invasive brain stimulation was more effective than conventional rehabilitation in lowering the scores of Childhood Autism Rating Scale, Autism Behavior Checklist, Autism Treatment Evaluation Checklist, and Repetitive Behavior Scale-Revised. (2) The network meta-analysis showed that compared with conventional rehabilitation, high-frequency repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex [MD=-6.00, 95%CI(-8.68, -3.33), P < 0.05, SUCRA=89.5%] was most effective in improving Childhood Autism Rating Scale scores, while high-frequency repetitive transcranial magnetic stimulation over Broca's area [MD=-15.11, 95%CI(-18.28, -11.95), P < 0.05, SUCRA=91.1%] was most effective in improving Autism Behavior Checklist scores. CONCLUSION: Current evidence indicates that high-frequency repetitive transcranial magnetic stimulation is most effective in improving core symptoms in children with autism. Due to the dual limitations of methodological heterogeneity and limited sample size in the included studies, large-sample, methodologically rigorous randomized controlled trials are urgently needed to further verify the reliability of these conclusions.

1. Introduction

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by core symptoms of social communication and interaction deficits, restricted and repetitive behaviors or interests, and often manifests as cognitive, behavioral, emotional, and language expression disorders, accompanied by a range of psychiatric issues such as attention deficit hyperactivity disorder and sleep disorders [1]. According to data from the U.S. Centers for Disease Control and Prevention in 2020, the overall prevalence of ASD in children has risen to 1 in 44, surpassing the combined prevalence of the three major diseases worldwide, with a male-to-female ratio of 3.8:1 [2]. ASD has a significant negative impact on the well-being of affected children and their families; studies have found that parents of children with ASD report lower levels of physical health, mental health, social health, and quality of life compared to parents of typically developing children [3]. The etiology of ASD remains unclear, but it is generally believed to result from multiple factors, with genetic and environmental factors playing important roles in its onset and development [4].

Pharmacological treatments can address comorbid psychiatric issues but do not directly treat the core symptoms of ASD. Therefore, exploring non-pharmacological therapies that can improve core symptoms is crucial [5]. However, existing non-pharmacological therapies generally have limitations such as slow onset and long treatment duration. For example, behavioral therapy requires long-term high-intensity training with significant individual variability in efficacy [6], and sensory integration training lacks standardized protocols and sufficient evidence [7]. In contrast, non-invasive brain stimulation (NIBS) offers unique advantages by directly modulating neural circuits, providing targeted, rapid effects, and the potential to synergistically enhance other therapies, offering a new approach to improving core symptoms of ASD [8]. NIBS is a neuromodulation technique that applies electrical or magnetic stimulation to the scalp to modulate cortical neural activity, with mechanisms including altering cortical excitability and inducing neuroplasticity for long-term functional improvement [9]. Currently, NIBS modalities used clinically to improve core symptoms in children with ASD include repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), transcranial pulse stimulation (TPS), intermittent theta burst stimulation (iTBS), and continuous theta burst stimulation (cTBS). Studies have confirmed that NIBS can improve restricted, repetitive behaviors and social deficits in children with ASD, but the efficacy varies across different stimulation protocols [10-11]. Existing meta-analyses have mostly focused on the efficacy of a single stimulation modality on core symptoms of ASD and have not compared different NIBS protocols [12-13]. Although some network meta-analyses have explored the efficacy differences among different NIBS interventions for ASD, they have primarily focused on tDCS and have not systematically included studies on rTMS and TPS [14].

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Fang Enhui, Guan Hui, Ma Lihong (2026). Non-invasive brain stimulation for core symptoms in children with autism spectrum disorder: a network meta-analysis. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21306
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the most effective non-invasive brain stimulation for improving core symptoms in children with autism?

According to this network meta-analysis, high-frequency repetitive transcranial magnetic stimulation (rTMS) is the most effective, with specific targets depending on the outcome measure: dorsolateral prefrontal cortex for Childhood Autism Rating Scale scores and Broca's area for Autism Behavior Checklist scores.

How many studies and participants were included in this meta-analysis?

The meta-analysis included 27 randomized controlled trials with a total of 1,701 children with autism spectrum disorder, covering 10 different non-invasive brain stimulation protocols.

What outcome measures were used to assess core symptoms?

The core symptoms were assessed using the Childhood Autism Rating Scale (CARS), Autism Behavior Checklist (ABC), Autism Treatment Evaluation Checklist (ATEC), and Repetitive Behavior Scale-Revised (RBS-R).

What are the limitations of this study?

The included studies had methodological heterogeneity and limited sample sizes, which may affect the reliability of the conclusions. Therefore, large-sample, methodologically rigorous randomized controlled trials are needed to confirm the findings.

What is the clinical implication of this study?

The findings suggest that high-frequency rTMS could be a promising intervention for improving core symptoms in children with autism, but clinicians should consider individual patient factors and the need for further evidence before routine application.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF